SCHEMBL16660942

SCHEMBL16660942

FC(F)(F)c1nnc(-c2ccc(Cl)nc2)[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.44
RAB9A P51151 2/20 0.44
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
PIK3CD O00329 1/20 0.40
NOTUM Q6P988 1/20 0.38
CYP2A6 P11509 1/20 0.38
HSD17B10 Q99714 2/20 0.34
HTT P42858 1/20 0.34
AKR1C3 P42330 1/20 0.34
AKR1C2 P52895 1/20 0.34
HDAC1 Q13547 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33
CHRNB2 P17787 3/20 0.33
CHRNA7 P36544 2/20 0.33
CHRNA4 P43681 2/20 0.33
CHRNA3 P32297 2/20 0.33
KCNQ3 O43525 1/20 0.33
KCNQ2 O43526 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15134178 0.75 NPC1 (0.47) NPC1RAB9AALDH1A1KDM4EPIK3CD
SCHEMBL16660830 0.73 TRPV1 (0.47) KDM4E
SCHEMBL16599396 0.73 KIF11 (0.44) NPC1RAB9AALDH1A1KDM4EHSD17B10
SCHEMBL38659101 0.71 KIF11 (0.47) NPC1RAB9AALDH1A1KDM4EHSD17B10
SCHEMBL15133020 0.71 NPC1 (0.44) NPC1RAB9AALDH1A1KDM4EPIK3CD
SCHEMBL22165974 0.71 NPC1 (0.44) NPC1RAB9AALDH1A1KDM4EPIK3CD
SCHEMBL29429388 0.71 NPC1 (0.44) NPC1RAB9AALDH1A1KDM4EPIK3CD
SCHEMBL25243396 0.70 CYP2A6 (0.37) KDM4ECYP2A6HSD17B10HTT
SCHEMBL16661271 0.68 NPC1 (0.51) NPC1RAB9AALDH1A1KDM4EPIK3CD
SCHEMBL1744141 0.68 KIF11 (0.52) PIK3CDNOTUMCYP2A6KCNQ3KCNQ2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10308636-B2 Aromatic heterocyclic compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2019-06-04 US disclosed
US-20170050950-A1 AROMATIC HETEROCYCLIC COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2017-02-23 US disclosed
US-20170050950-A1 AROMATIC HETEROCYCLIC COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2017-02-23 US disclosed
US-9546155-B2 Aromatic heterocyclic compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2017-01-17 US disclosed
US-9546155-B2 Aromatic heterocyclic compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2017-01-17 US disclosed
US-20150158844-A1 AROMATIC HETEROCYCLIC COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2015-06-11 US disclosed
US-20150158844-A1 AROMATIC HETEROCYCLIC COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2015-06-11 US disclosed
EP-2862856-A1 AROMATIC HETEROCYCLIC COMPOUND Mitsubishi Tanabe Pharma Corporation (JP) 2015-04-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150158844-A1 AROMATIC HETEROCYCLIC COMPOUND GPR119, NR0B1, BET1 NPC1 796/4885RAB9A 3324/4885ALDH1A1 887/4885
US-10308636-B2 Aromatic heterocyclic compound GPR119, NR0B1, BET1 NPC1 796/4885RAB9A 3324/4885ALDH1A1 887/4885
US-20170050950-A1 AROMATIC HETEROCYCLIC COMPOUND GPR119, NR0B1, BET1 NPC1 796/4885RAB9A 3324/4885ALDH1A1 887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.